Release Date:  February 9, 2000

PA NUMBER:  PA-00-056
National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Diabetes and Digestive and Kidney Disease



The National Institute on Aging (NIA), the National Institute of Arthritis 
and Musculoskeletal and Skin Diseases(NIAMS), and the National Institute of 
Diabetes and Digestive and Kidney Diseases (NIDDK) invite exploratory 
research grant applications (R21) for studies of whether aging and/or chronic 
diseases common to old age, may negatively impact on skeletal muscle 
perfusion and thereby lead to potential metabolic disorders or limit physical 
performance in older persons.  The current understanding of potential changes 
in skeletal muscle perfusion in old age and its consequences remains 
equivocal in nature. With the recent advent of improved tools to measure 
skeletal muscle perfusion and to examine the muscle microvasculature, it is 
anticipated that exploratory studies utilizing these new methodologies will 
help to identify the most promising experimental approaches to address 
fundamental issues regarding the skeletal muscle microvasculature and blood 
supply in old age. 


The Public Health Service (PHS) is committed to achieving the health 
promotion and disease prevention objectives of  “Healthy People 2000,” a PHS-
led national activity for setting priority areas.  This program announcement 
(PA), Skeletal Muscle Perfusion, Aging and Cardiovascular Disease, is related 
to the priority areas of physical activity and fitness and diabetes and 
chronic diseases disabling conditions. Potential applicants may obtain a copy 
of “Healthy People 2000” at


Applications for exploratory grants (R21) may be submitted by domestic and 
foreign for-profit and non-profit organizations, public and private, such as 
universities, colleges, hospitals, laboratories, units of state and local 
governments, and eligible agencies of the Federal government. Racial/ethnic 
minority individuals, women, and persons with disabilities are encouraged to 
apply as principal investigators.  Applications may include collaborative 
arrangements between scientists from a single institution or multiple 
institutions.  Simultaneous submission of the same research project as both 
an exploratory grant and a regular research grant (R01) is not permitted.

The mechanism of support will be the NIH exploratory grant mechanism (R21). 
Applicants may request up to $150,000 per year in direct costs when 
applications are from a single institution with no collaborating institutions 
and $175,000 when there are two or more institutions collaborating.  Specific 
application instructions have been modified to reflect "MODULAR GRANT" and 
"JUST-IN-TIME" streamlining efforts being examined by NIH. Complete and 
detailed instructions and information on Modular Grant applications can be 
found at: Because 
the nature and the scope of the research proposed in response to this PA may 
vary, it is anticipated that the size of the awards will vary as well.  The 
total project period for an R21 application submitted in response to this PA 
may not exceed two years. Responsibility for the planning, direction, and 
execution of the proposed R21 project will be solely that of the applicant. 
These grants are non-renewable and continuation of projects developed under 
this program will be through the traditional unsolicited grants program. 


Approximately $750,000 in total costs for the first year of funding will be 
made available by the National Institute on Aging to fund applications 
submitted in response to this PA. Although NIAMS and NIDDK have not set aside 
specific funds for this announcement, individual applications that are 
assigned to either institute will be considered for funding along with other 
program priorities based upon their relative scientific merit. Awards made 
will be contingent upon availability of funds and the receipt of a sufficient 
number of applications of outstanding scientific and technical merit. Direct 
costs will be awarded in modules of $25,000, less any overlap or other 
necessary administrative adjustments. 



The performance of a wide variety of tasks require that pulmonary function 
and cardiac pumping capacity adapt to the oxygen and nutrient demands of the 
contracting muscle groups. The ability of active skeletal muscle to meet its 
metabolic and functional demands also depends on the function of its own 
microvasculature. For example, changes in capillary density or altered 
responsiveness to local mediators of blood flow could limit the supply of 
blood and nutrients to skeletal muscle. Therefore, under normal 
circumstances, the lungs, the heart and the peripheral circulation have to 
work together to ensure adequate blood supply to contracting muscles.  In 
older persons, an insufficient blood supply to skeletal muscle may contribute 
to some metabolic disorders (e.g., insulin insensitivity by limiting 
peripheral glucose uptake) and to physical functional problems. Potential 
mechanisms underlying compromised muscle blood flow in the elderly could 
involve: 1) age-related reductions in skeletal muscle mass and/or detrimental 
changes in its intrinsic properties, 2) age-associated dysfunction of the 
central and peripheral circulation, and 3) secondary effects of chronic 
diseases common to old age (e.g., hypertension, diabetes). Unfortunately 
there is limited data on if or how skeletal muscle perfusion changes with 
increasing age and/or with diseases common to old age, such as congestive 
heart failure, peripheral vascular disease, pulmonary disease and diabetes. 
Thus a clear understanding of the metabolic and physical functional 
consequences of such changes is lacking, as well. 

To address these issues, the NIA organized the workshop, “Changes in Skeletal 
Muscle Blood Supply with Aging and Disease” which was held on May 12-13, 
1998.  The specific goals of this workshop were to convene investigators in 
muscle physiology and cardiovascular research to review the current knowledge 
base on the regulation of  blood flow to muscle and structure/function of the 
skeletal muscle microvasculature as well as, to identify future research 
directions in elucidating the role of impaired skeletal muscle perfusion in 
physical functional problems of the elderly. The specific research areas 
discussed included: 1) changes in the central and peripheral regulation of 
skeletal muscle blood flow with advancing age, 2) age-related changes in the 
structure and function of the skeletal muscle microvasculature, and 3) impact 
of chronic diseases on skeletal muscle blood supply and its regulation.  This 
PA seeks to promote the research priorities identified at the workshop.

Objectives and Scope

This initiative will provide research support for exploratory/pilot studies 
of potential changes in skeletal muscle blood flow/perfusion due to aging 
and/or chronic diseases common to old age.  Applications submitted in 
response to this PA should explore the mechanism(s) by which changes in 
skeletal muscle blood supply could contribute to metabolic and/or physical 
functional problems often noted in older persons.  Topics of interest 
include, but are not limited to:
o  Characterization of the metabolic and/or physical functional consequences 
of age-associated and disease-related changes in the skeletal muscle 

o  Studies of the interrelationship(s) between pulmonary, cardiac and 
skeletal muscle function during rest and at times of submaximal exercise in 
older individuals

o  Development of novel rehabilitation strategies to improve hemodynamics in 
older patients with vascular diseases (e.g., peripheral vascular disease, 

o  Exploration of factors/mechanisms associated with age-related decreases in 
maximum cardiac output that may limit skeletal muscle perfusion and function. 
These mechanisms may include age-related alterations in left ventricular end 
diastolic volume, competency of venous valves and arterial stiffness

o  Investigation of changes in autonomic responsiveness (e.g., maximum heart 
rate, left ventricular contractility, ejection fraction) that may influence 
blood supply to skeletal muscle.

o  Potential changes in pulmonary function related to aging or disease, that 
may affect adequate oxygen delivery to active skeletal muscle.

o  Influence of age, physical activity/inactivity and or chronic diseases on 
the plasticity of the skeletal muscle vascular system.   

o  Influence of altered blood flow on progression of diabetic complications 
such as neuropathy and diabetic foot.

o  Development and validation of appropriate animal models to examine changes 
in skeletal muscle microvasculature due to aging and/or disease. 

o  Improved quantitative measures of vascular changes in skeletal muscle and 
blood flow heterogeneity, including dynamic measures.


It is the policy of the NIH that women and members of minority groups and 
their sub-populations must be included in all NIH supported biomedical and 
behavioral research projects involving human subjects, unless a clear and 
compelling rationale and justification is provided that inclusion is 
inappropriate with respect to the health of the subjects or the purpose of 
the research.  This policy results from the NIH Revitalization Act of 1993 
(Section 492B of Public Law 103-43).

All investigators proposing research involving human subjects should read the 
"NIH Guidelines For Inclusion of Women and Minorities as Subjects in Clinical 
Research," which have been published in the Federal Register of March 28, 
1994 (FR 59 14508-14513) and in the NIH Guide for Grants and Contracts, 
Volume23, Number 11, March 18, 1994, 

Investigators also may obtain copies of the policy from the program staff 
listed under INQUIRIES.  Program staff may provide additional information 
concerning the policy.


Applications are to be submitted on grant application form PHS 398 (rev. 
4/98) and will be accepted at the standard application deadlines as indicated 
in the application kit.  Application kits are available at most institutional 
offices of sponsored research and may be obtained from the Division of 
Extramural Outreach and Information Resources,  National Institutes of 
Health, 6701 Rockledge Drive, MSC 7910, Bethesda, MD 20892-7910, Phone (301) 
710-0267, Email:  GRANTSINFO@NIH.GOV. Applications are also available on the 
internet at

Submit a signed, typewritten, original of the application, including the 
checklist and five signed photocopies in one package to:

BETHESDA, MD 20892-7710
BETHESDA, MD 20817 (for express/courier service)

The title and number of this program announcement must be typed on line 2 of 
the face page of the application form and the YES box must be marked.


The modular grant concept establishes specific modules in which direct costs 
may be requested as well as a maximum level for requested budgets. Only 
limited budgetary information is required under this approach. The just-in-
time concept allows applicants to submit certain information only when there 
is a possibility for an award. It is anticipated that these changes will 
reduce the administrative burden for the applicants, reviewers and Institute 
staff. The research grant application form PHS 398 (rev. 4/98) is to be used 
in applying for these grants, with the modifications noted below.


As specified in the MECHANISM OF SUPPORT, applicants may request up to 
$150,000 or $175,000 in direct costs based on the number of collaborating 
institutions. These costs should be requested in $25,000 modules, up to a 
total direct cost request of $150,000 per year when there is a single 
institution involved (no collaborating institutions), or up to a total direct 
cost request of $175,000 when two or more institutions are collaborating. The 
total direct costs must be requested in accordance with the program 
guidelines and the modifications made to the standard PHS 398 application 
instructions described below:

PHS 398

o  FACE PAGE: Items 7a and 7b should be completed, indicating Direct Costs 
(in $25,000 increments up to a maximum of $150,000 or $175,000 based on the 
number of  collaborating institutions) and Total Costs [Modular Total Direct 
plus Facilities and Administrative (F&A) costs] for the initial budget 
period.  Items 8a and 8b should be completed indicating the Direct and Total 
Costs for the entire proposed period of support.

4 of the PHS 398.  It is not required and will not be accepted with the 

categorical budget table on Form Page 5 of the PHS 398.  It is not required 
and will not be accepted with the application.

NARRATIVE BUDGET JUSTIFICATION - Prepare a Modular Grant Budget Narrative 
page. (See for 
sample pages.)  At the top of the page, enter the total direct costs 
requested for each year. This is not a Form page.

o  Under Personnel, list key project personnel, including their names, 
percent of effort, and roles on the project. No individual salary information 
should be provided. However, the applicant should use the NIH appropriation 
language salary cap and the NIH policy for graduate student compensation in 
developing the budget request.

For Consortium/Contractual costs, provide an estimate of total costs (direct 
plus facilities and administrative) for each year, each rounded to the 
nearest $1,000.  List the individuals/ organizations with whom consortium or 
contractual arrangements have been made, the percent effort of key personnel, 
and the role on the project. Indicate whether the collaborating institution 
is foreign or domestic. The total cost for a consortium/contractual 
arrangement is included in the overall requested modular direct cost amount. 
Include the Letter of Intent to establish a consortium.

Provide an additional narrative budget justification for any variation in the 
number of modules requested.

o  BIOGRAPHICAL SKETCH - The Biographical Sketch provides information used by 
reviewers in the assessment of each individual's qualifications for a 
specific role in the proposed project, as well as to evaluate the overall 
qualifications of the research team.  A biographical sketch is required for 
all key personnel, following the instructions below.  No more than three 
pages may be used for each person.  A sample biographical sketch may be 
viewed at:

- Complete the educational block at the top of the form page;
- List position(s) and any honors;
- Provide information, including overall goals and responsibilities, on 
research projects ongoing or completed during the last three years;
- List selected peer-reviewed publications, with full citations.

o  CHECKLIST - This page should be completed and submitted with the 
application.  If the F&A rate agreement has been established, indicate the 
type of agreement and the date. All appropriate exclusions must be applied in 
the calculation of the F&A costs for the initial budget period and all future 
budget years.

o  The applicant should provide the name and phone number of the individual 
to contact concerning fiscal and administrative issues if additional 
information is necessary following the initial review.


Applications will be assigned on the basis of established Public Health 
Service referral guidelines.  Applications that are complete will be 
evaluated for scientific and technical merit by an appropriate peer review 
group convened in accordance with NIH peer review procedures. As part of the 
initial merit review, all applications will receive a written critique and 
undergo a process in which only those applications deemed to have the highest 
scientific merit, generally the top half of applications under review, will 
be discussed, assigned a priority score, and receive a second level review by 
the appropriate national advisory council or board.

Review Criteria

The goals of NIH-supported research are to advance our understanding of 
biological  systems, improve the control of disease, and enhance health. In 
the written comments  reviewers will be asked to discuss the following 
aspects of the application in order to  judge the likelihood that the 
proposed research will have a substantial impact on the  pursuit of these 
goals. Each of these criteria will be addressed and considered in assigning 
the overall score, weighting them as appropriate for each application. Note 
that the application does not need to be strong in all categories to be 
judged likely to have major scientific impact and thus deserve a high 
priority score. For example, an  investigator may propose to carry out 
important work that by its nature is not innovative  but is essential to move 
a field forward.

1.  Significance:  Does this study address an important problem?  If the aims 
of the application are achieved, how will scientific knowledge be advanced?  
What will be the effect of these studies on the concepts or methods that 
drive this field?

2.  Approach:  Are the conceptual framework, design, methods, and analyses 
adequately developed, well-integrated, and appropriate to the aims of the 
project?  Does the applicant acknowledge potential problem areas and consider 
alternative tactics?

3.  Innovation:  Does the project employ novel concepts, approaches or 
method? Are the aims original and innovative?  Does the project challenge 
existing paradigms or develop new methodologies or technologies?

4.  Investigator:  Is the investigator appropriately trained and well suited 
to carry out this work?  Is the work proposed appropriate to the experience 
level of the principal investigator and other researchers (if any)?

5.  Environment:  Does the scientific environment in which the work will be 
done contribute to the probability of success?  Do the proposed experiments 
take advantage of unique features of the scientific environment or employ 
useful collaborative arrangements? Is there evidence of institutional 

In addition to the above criteria, in accordance with NIH policy, all 
applications will also be reviewed with respect to the following:

o  The adequacy of plans to include both genders, minorities, and their 
subgroups, and children as appropriate for the scientific goals of the 
research.  Plans for the recruitment and retention of subjects will also be 

o  The reasonableness of the proposed budget and duration in relation to the 
proposed research.

o  The adequacy of the proposed protection for humans, animals or the 
environment, to the extent they may be adversely affected by the project 
proposed in the application.

Applications will compete for available funds with all other recommended 
applications.  The following will be considered in making funding decisions:

o  Quality of the proposed project as determined by peer review
o  Availability of funds
o  Program priority.

Inquiries are encouraged. The opportunity to clarify any issues or questions 
from potential applicants is welcome.
Direct inquiries regarding programmatic issues to:
Chhanda Dutta, PhD
Geriatrics Program
National Institute on Aging
7201 Wisconsin Avenue, Suite 3E-327 MSC 9205
Bethesda, MD  20892-9205
Telephone:  (301) 435-3048

Richard W. Lymn, Ph.D.
Muscle Biology Program
National Institute of Arthritis and Musculoskeletal and Skin
Diseases 45 Center Drive, MSC 6500
Bethesda, MD  20892-6500
Telephone:  (301) 594-5128
FAX:  (301) 480-4543

Maren R. Laughlin, Ph.D.
Metabolism Program
National Institute of Diabetes, and Digestive and Kidney Disease
Room 6101, MSC 5460
6707 Democracy Boulevard
Bethesda, MD  20892-5460
Telephone: (301) 594-8802
Direct inquiries regarding fiscal matters to:
Cynthia Riddick
Grants and Contracts Management Office
National Institute on Aging
7201 Wisconsin Avenue, Suite 2N212, MSC 9205
Bethesda, MD  20892-9205
Telephone:  (301) 496-1472
FAX:  (301) 402-3672

Ms. Melinda Nelson
Grants Management Branch
National Institute of Arthritis and Musculoskeletal and Skin Diseases 
45 Center Drive, MSC 6500
Bethesda, MD  20892-6500
Telephone:  (301) 435-5278
FAX:  (301) 480-5450

Mary Kay Rosenberg
Grants Management Specialist
Building 45, Room 6AS-49D
45 Center Drive, MSC 6600
Bethesda, MD  20892-6600
(301) 594-8891 phone
(301) 480-3504 FAX

This program is described in the Catalog of Federal Domestic Assistance No. 
93.866, Aging Research, No. 93.846, Arthritis and Musculoskeletal and Skin 
Diseases Research and No. 93.847,Diabetes, and Digestive and Kidney Disease 
Research. Awards are made under authorization of the Public Health Service 
Act, Title IV, Part A (Public Law 78-410), as amended by Public Law 99-158, 
42 USC 241 and 285) and administered under PHS grants policies and Federal 
Regulations 42 CFR 52 and 45 CFR Part 74. This program is not subject to the 
intergovernmental review requirements of Executive Order 12372 or Health 
Systems Agency review.
The PHS strongly encourages all grant and contract recipients to provide a 
smoke-free workplace and promote the non-use of all tobacco products.  In 
addition, Public Law 103-227, the Pro-Children Act of 1994, prohibits smoking 
in certain facilities (or in some cases, any portion of a facility) in which 
regular or routine education, library, day care, health care or early 
childhood development services are provided to children.  This is consistent 
with the PHS mission to protect and advance the physical and mental health of 
the American people.

Return to Volume Index

Return to NIH Guide Main Index

Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS) - Government Made Easy

Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.